Source - SMW
Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p).

Related Charts

GlaxoSmithKline (GSK)

-1.50p (-0.10%)
delayed 18:15PM